ImmunoGen, Inc. (NASDAQ:IMGN) Receives Average Recommendation of “Hold” from Analysts

Retrieved on: 2022-06-11 12:38:10

Tags for this article:

Click the tags to see associated articles and topics

ImmunoGen, Inc. (NASDAQ:IMGN) Receives Average Recommendation of “Hold” from Analysts. View article details on hiswai:

Excerpt

Bank of America Corp DE now owns 1,460,432 shares of the biotechnology company's stock worth $6,951,000 after acquiring an additional 376,567 ...

Article found on: www.etfdailynews.com